MNOV

Medicinova Inc Cross-source read$1.81 4.02%
Health CareCUSIP 58468P206· EOD Sep 11, 2026

Among active 13F managers last quarter, 3 opened and 2 added, while 3 reduced; the largest holder to move was Renaissance Technologies LLC (−3.5%). No open-market insider trades in the last 180 days.

Tracked 13F holders
30
6 in Q2 2026 filings
13F value (tracked)
$5.8M
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
5 adding · 3 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$1.81 4.02%5Y -54.1%
$0.91$1.72$2.53$3.35$4.162021202220232024202520261474484435435366433353873536532533832
Hover for who · click for detailEnd-of-day closing prices52w $1.18 – $1.88

Who owns MNOV?

30 tracked 13F filers · ranked by shares held

30 tracked 13F filers disclose a position in MNOV as of the latest SEC 13F filings, a combined $5.8M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1BlackRock, Inc.752K
$993K
+6.5%
Added · +46K sh
Q2 2026
2Citigroup Inc636K
$871K
Held
Q1 2026
3Vanguard Capital Management LLC609K
$804K
−0.3%
Reduced · −2K sh
Q2 2026
4Geode Capital Management, LLC539K
$712K
−0.8%
Reduced · −5K sh
Q2 2026
5Vanguard Fiduciary Trust Co283K
$373K
+0.7%
Added · +2K sh
Q2 2026
6UBS Group AG222K
$304K
−1.5%
Reduced · −3K sh
Q1 2026
7State Street Corp194K
$256K
Held
Q2 2026
8Renaissance Technologies LLC190K
$260K
−3.5%
Reduced · −7K sh
Q1 2026
9Barclays PLC163K
$223K
+313%
Added · +124K sh
Q1 2026
10Northern Trust Corp133K
$182K
Held
Q1 2026
11Jane Street Group, LLC87K
$119K
−47%
Reduced · −76K sh
Q1 2026
12Bank of New York Mellon Corp78K
$107K
−19%
Reduced · −18K sh
Q1 2026
13Charles Schwab Investment Management Inc72K
$98K
Held
Q1 2026
14Bridgeway Capital Management, LLC56K
$74K
Held
Q2 2026
15SBI Securities Co., Ltd.51K
$68K
+15%
Added · +7K sh
Q2 2026
16Dimensional Fund Advisors LP51K
$69K
−22%
Reduced · −14K sh
Q1 2026
17Susquehanna International Group, LLP44K
$60K
+93%
Added · +21K sh
Q1 2026
18Schonfeld Strategic Advisors LLC36K
$48K
−0.6%
Reduced · −219 sh
Q2 2026
19Bank Of America Corp34K
$47K
+15%
Added · +4K sh
Q1 2026
20Two Sigma Investments, LP30K
$41K
−25%
Reduced · −10K sh
Q1 2026
21Goldman Sachs Group Inc28K
$38K
+5.1%
Added · +1K sh
Q1 2026
22JPMorgan Chase & Co21K
$28K
36×
Added · +20K sh
Q1 2026
23Vanguard Global Advisers, LLC16K
$21K
Held
Q2 2026
24XTX Topco Ltd14K
$19K
New
+14K sh
Q1 2026
25Focus Advisor Solutions, LLC10K
$13K
Added
Added · +10K sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is MNOV being bought or sold by institutions?

Last quarter, 3 funds opened a new position in MNOV and 2 added to an existing one, while 3 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
3
funds took a first position
Added
2
added to an existing position
Reduced
3
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own MNOV also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA9 funds$3.7B
Apple IncAAPL9 funds$2.8B
Alphabet Inc-CL AGOOGL9 funds$1.9B
Tesla IncTSLA9 funds$1.4B
JPMorgan Chase & CoJPM9 funds$1.3B
Costco Wholesale CorpCOST9 funds$955.9M
Berkshire Hathaway Inc-CL BBRK/B9 funds$949.1M
Verisign IncVRSN9 funds$875.5M
Unitedhealth Group IncUNH9 funds$865.8M
Bristol-Myers Squibb CoBMY9 funds$770.5M
Chevron CorpCVX9 funds$757.7M
Exelixis IncEXEL9 funds$694.9M

Ranked by how many of MNOV's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in MNOV.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Nov 28, 2022Nagao HidekiDirectorSell (S)7K$15K
Nov 22, 2022Nagao HidekiDirectorSell (S)218$464
Nov 21, 2022Nagao HidekiDirectorSell (S)5K$12K
Nov 17, 2022Nagao HidekiDirectorSell (S)309$674
Mar 11, 2021Nagao HidekiDirectorSell (S)2K$17K
Sep 15, 2020Nagao HidekiDirectorSell (S)1K$6K
Mar 13, 2020Matsuda KazukoChief Medical Officer, DirectorBuy (P)2K$7K
Mar 12, 2020Iwaki YuichiPresident and CEO, DirectorBuy (P)20K$62K
Aug 21, 2017Ishizaka YoshioDirectorBuy (P)5K$26K
May 15, 2017Kobayashi YutakaDirectorBuy (P)1K$6K
May 12, 2017Kobayashi YutakaDirectorBuy (P)24K$135K
Sep 15, 2016Kobayashi YutakaDirectorBuy (P)12K$76K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
99
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
MNOV is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

6 tracked filers in Q2 2026 filingsstill filing
01530Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $1.1M
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for MNOV

Browse more

Build

Ask your agent what changed in MNOV

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/MNOV/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for MNOV.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for MNOV. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.